ALEMBIC PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of ALEMBIC PHARMACEUTICALS have increased by 10.08% YoY .
The Earnings Per Share (EPS) of ALEMBIC PHARMACEUTICALS has increased by 15.67 % YoY. |
||
ALEMBIC PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 533573|NSE : APLLTD]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹7,345 Cr | ₹6,672 Cr | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr |
| Expenses | ₹6,227 Cr | ₹5,669 Cr | ₹5,296 Cr | ₹4,945 Cr | ₹4,432 Cr |
| Operating Profit (Excl OI) | ₹1,118 Cr | ₹1,003 Cr | ₹933 Cr | ₹708 Cr | ₹874 Cr |
| Other Income | ₹55 Cr | ₹48 Cr | ₹29 Cr | ₹3.04 Cr | ₹50 Cr |
| Interest | ₹94 Cr | ₹79 Cr | ₹56 Cr | ₹50 Cr | ₹18 Cr |
| Depreciation | ₹319 Cr | ₹279 Cr | ₹273 Cr | ₹275 Cr | ₹287 Cr |
| Profit Before Tax | ₹694 Cr | ₹707 Cr | ₹632 Cr | ₹355 Cr | ₹625 Cr |
| Profit After Tax | ₹671 Cr | ₹582 Cr | ₹616 Cr | ₹342 Cr | ₹521 Cr |
| Consolidated Net Profit | ₹675 Cr | ₹583 Cr | ₹616 Cr | ₹342 Cr | ₹521 Cr |
| Earnings Per Share (Rs) | ₹34.33 | ₹29.68 | ₹31.33 | ₹17.40 | ₹26.50 |
| PAT Margin (%) | 4.71 | 4.34 | 9.89 | 6.05 | 9.82 |
| ROE(%) | 12.35 | 11.63 | 13.40 | 7.12 | 10.11 |
| ROCE(%) | 11.74 | 13.51 | 13.42 | 7.44 | 11.25 |
| Total Debt/Equity(x) | 0.24 | 0.23 | 0.09 | 0.15 | 0.12 |
Key Financials |
||
| Market Cap | : | ₹ 16,384.6 Cr |
| Revenue (TTM) | : | ₹ 7,344.9 Cr |
| Net Profit(TTM) | : | ₹ 670.6 Cr |
| EPS (TTM) | : | ₹ 34.1 |
| P/E (TTM) | : | 24.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC PHARMACEUTICALS | -2% | 9.4% | -18.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% | 6.8% | 16.3% |
| DIVIS LABORATORIES | 0.6% | 8.7% | 7.9% |
| TORRENT PHARMACEUTICALS | 0.4% | 13.8% | 46.9% |
| CIPLA | -0.4% | 5.8% | -2.9% |
| DR REDDYS LABORATORIES | -1.9% | -5.1% | -2.2% |
| MANKIND PHARMA | 1.2% | 6.6% | -5% |
| LUPIN | 0.9% | 6.9% | 28.8% |
| ZYDUS LIFESCIENCES | -0.9% | 6.8% | 18.4% |
ALEMBIC PHARMACEUTICALS Revenues
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 10.08 % |
| 5 Yr CAGR | 8.47 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,345 Cr | 10.08 | |
| Mar2025 | ₹6,672 Cr | 7.12 | |
| Mar2024 | ₹6,229 Cr | 10.19 | |
| Mar2023 | ₹5,653 Cr | 6.54 | |
| Mar2022 | ₹5,306 Cr | - | |
ALEMBIC PHARMACEUTICALS Operating Profit
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 11.47 % |
| 5 Yr CAGR | 6.34 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,118 Cr | 11.47 | |
| Mar2025 | ₹1,003 Cr | 7.54 | |
| Mar2024 | ₹933 Cr | 31.72 | |
| Mar2023 | ₹708 Cr | -19.00 | |
| Mar2022 | ₹874 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 1.26 % |
| 5 Yr CAGR | -1.97 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 15.22% | 1.26 | |
| Mar2025 | 15.03% | 0.40 | |
| Mar2024 | 14.97% | 19.47 | |
| Mar2023 | 12.53% | -23.97 | |
| Mar2022 | 16.48% | - | |
ALEMBIC PHARMACEUTICALS Profit After Tax
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 15.66 % |
| 5 Yr CAGR | 6.68 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹675 Cr | 15.66 | |
| Mar2025 | ₹583 Cr | -5.26 | |
| Mar2024 | ₹616 Cr | 80.07 | |
| Mar2023 | ₹342 Cr | -34.35 | |
| Mar2022 | ₹521 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 8.53 % |
| 5 Yr CAGR | -16.78 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 4.71 % | 8.53 | |
| Mar2025 | 4.34 % | -56.12 | |
| Mar2024 | 9.89 % | 63.47 | |
| Mar2023 | 6.05 % | -38.39 | |
| Mar2022 | 9.82 % | - | |
ALEMBIC PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 15.67 % |
| 5 Yr CAGR | 6.69 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹34 | 15.67 | |
| Mar2025 | ₹30 | -5.27 | |
| Mar2024 | ₹31 | 80.06 | |
| Mar2023 | ₹17 | -34.34 | |
| Mar2022 | ₹27 | - | |
ALEMBIC PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | -13.10 % |
| 5 Yr CAGR | 1.07 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 11.74% | -13.10 | |
| Mar2025 | 13.51% | 0.67 | |
| Mar2024 | 13.42% | 80.38 | |
| Mar2023 | 7.44% | -33.87 | |
| Mar2022 | 11.25% | - | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹833.4 |
| Current MarketCap | : | ₹ 16,384.6 Cr |
| Updated EOD on | : | Jul 21,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -2% |
9.4% |
-18.3% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
ALEMBIC PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | 0.7% | 0.8% | 0.3% |
| BSE HEALTHCARE | 0.5% | 6.3% | 13.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 MULTICAP 50:25:25 | 0.7% | 1.1% | 1.6% |
| NIFTY 500 EQUAL WEIGHT | 0.6% | 1.6% | 3.1% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 0.6% | 1.4% | 2.7% |
| NIFTY TOTAL MARKET | 0.6% | 0.7% | 0.5% |
| NIFTY MIDSMALLCAP400 50:50 | 0.6% | 2% | NA |
You may also like the below Video Courses
FAQ about ALEMBIC PHARMACEUTICALS Financials
How the annual revenues of ALEMBIC PHARMACEUTICALS have changed ?
The Revenues of ALEMBIC PHARMACEUTICALS have increased by 10.08% YoY .
How the Earnings per Share (EPS) of ALEMBIC PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of ALEMBIC PHARMACEUTICALS has increased by 15.67 % YoY .
Check out Intrinsic Value of Peers of ALEMBIC PHARMACEUTICALS
Compare Stock Analytics of Peers of ALEMBIC PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
